All Type of News
Many postmenopausal women in Korea worry over adverse effects of hormone replacement therapy: survey
The majority of postmenopausal women in Korea are concerned about side effects of hormone replacement therapy (HRT), a recent survey shows.
The survey of 100 women with one-year HRT treatment in Seoul and metropoli...
HIRA to undertake DUR-based computerized screening on 172 contraindicated combination drugs from...
HIRA to undertake DUR-based computerized screening on 172 contraindicated combination drugs from July
The Health Insurance Review Agency said on June 28 that based on the proposed drug utilization review system (DU...
Boryung to introduce wellbeing drink, Amino Plus.Boryung introduced a wellbeing drink preparation, Amino Plus, formulated with 11 amino acids, vitamin B1 and B2 for the recovery of fatigue and exhausted body conditions.
It ...
|
HIRA to disclose 6 review guidelines.
The Health Insurance Review Agency (HIRA) held the Central Review Coordination Committee on June 21 to adopt 3 new review guidelines and 3 guideline changes.
In the meeting, they determined 6 review guidelines inc...
Korea's drug output totaled 9.5 trillion won in 2003
Korea's total drug production by 679 manufacturers was 9.5 trillion won in 2003, up 3.65 percent compared with 9.1 trillion won a year earlier, according to data from the Korea Pharmaceutical Manufacturers Association...
Many Korean pharmaceutical firms want to enter glimepiride market
In coming autumn, Hadok-Aventis Pharma will face an uphill battle in trying to protect its glimepiride market from domestic competition as 33 generic items of Amaryl (glimepiride), an oral antidiabetic agent, received...
GSK to launch Paxil CR in July
GSK unveiled its plan to launch Paxil (paroxetine HCl) controlled release tablet (12.5 mg) in July, which belongs to a class of the selective serotonin reuptake inhibitors (SSRIs) having broad range of efficacy in moo...
Mobile device DiabeticPhone to launch in pharmacy market.A new conceptual device for the control of diabetic management will be launched into the retail pharmacy market under the brand of "DiabeticPhone", which may keenly attract inte...
|
Korean pharmaceutical firms challenge Pfizer's Norvasc
Korean major pharmaceutical markers are set to challenge Pfizer's current lead in the domestic amlodipine market by strategically launching their novel amlopdipine salts for sales boost, according to industry sources ...
Pharmacy community denouncing drug wholesalers on puffed prices.
It was found that a wholesaler supplied drugs at puffed prices to a retail pharmacy, which gave serious business damages. When the pharmacy legally claimed and rejected its credit payment, the wholesaler counter attac...
